Company research
Echo Therapeutics, Inc.
CIK 1031927Updated Sep 25, 2026
Securities
Historical securities (1)
ECTE · NASDAQ · equity · closed Sep 3, 2021Name history
SONTRA MEDICAL CORP · through Oct 3, 2007CHOICETEL COMMUNICATIONS INC/MN/ · through Jul 1, 2002CHOICETEL COMMUNICATIONS INC /MN/ · through Jun 19, 2002
ECTE price & chart
Historical security
This listing closed Sep 3, 2021. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2015 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 805,090Source | 12,595,836Source | 23,089,295Source | 20,021,592Source |
| Property, Plant and Equipment, NetUSD | 267,671Source | 1,138,593Source | 1,495,807Source | 1,638,395Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 0Source | 9,625,000Source | 9,625,000Source | 9,625,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 56,210Source | 1,278,941Source | 8,055,385Source | 3,747,210Source |
| Assets, CurrentUSD | 300,744Source | 1,822,253Source | 9,375,098Source | 5,198,303Source |
| Prepaid Expense and Other Assets, CurrentUSD | 244,534Source | 490,824Source | 49,221Source | 75,626Source |
| Other Assets, NoncurrentUSD | 250Source | 9,990Source | 1,576Source | — |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 3,330,963Source | 3,073,551Source | 3,720,799Source | 9,790,986Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 111,243Source | 126,295Source | 117,764Source | 443,737Source |
| Additional Paid in CapitalUSD | 147,412,559Source | 137,292,157Source | 132,192,648Source | 103,658,724Source |
| Retained Earnings (Accumulated Deficit)USD | -150,129,933Source | -127,932,066Source | -112,969,412Source | -93,902,015Source |
| Stockholders' Equity Attributable to ParentUSD | -2,525,873Source | 9,522,285Source | 19,368,496Source | 10,230,606Source |
| Liabilities and EquityUSD | 805,090Source | 12,595,836Source | 23,089,295Source | 20,021,592Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 3,235,428Source | 2,978,016Source | 3,644,371Source | 9,578,563Source |
| Accounts Payable, CurrentUSD | 2,176,083Source | 1,801,469Source | 1,036,320Source | 2,319,219Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 602,345Source | 968,392Source | 1,411,107Source | 1,581,448Source |
| Deferred Revenue, CurrentUSD | — | — | 76,428Source | 90,228Source |
| Deferred Revenue, NoncurrentUSD | 95,535Source | 95,535Source | 76,428Source | 90,228Source |
cash flow · annual statements
| Line item | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 521,860Source | 392,727Source | 391,595Source | 145,155Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 910,884Source | 1,373,968Source | 1,244,342Source | 1,409,562Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | 37,065Source |
| Increase (Decrease) in Accounts PayableUSD | 656,556Source | 765,149Source | -1,282,899Source | 1,953,921Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -5,079,864Source | -10,724,603Source | -19,409,836Source | -10,287,665Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -113,692Source | 215,449Source | -144,032Source | -1,644,554Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 3,970,825Source | 3,732,710Source | 23,862,043Source | 6,683,858Source |
| Additional Financial Items | ||||
| Amortization of Debt Issuance CostsUSD | 0Source | 3,549,328Source | 968,004Source | 423,126Source |
| Deconsolidation, Revaluation of Retained Investment, Gain (Loss), AmountUSD | -81,155Source | 911,000Source | — | — |
| DepreciationUSD | — | 392,727Source | — | — |
| Derivative, Gain (Loss) on Derivative, NetUSD | — | — | 4,466,000Source | — |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD | -278,816Source | -1,114Source | — | — |
| Gain (Loss) on Disposition of AssetsUSD | 278,816Source | 1,114Source | — | — |
| Gain (Loss) on Sale of DerivativesUSD | 81,155Source | 911,000Source | 4,465,986Source | 3,683,676Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | -126,082Source | — | — | — |
| Income Tax Expense (Benefit)USD | 3,420Source | 4,000Source | — | — |
| Investment Income, InterestUSD | — | 978Source | 3,052Source | 5,466Source |
| Net Income (Loss) Attributable to ParentUSD | -22,197,867Source | -14,962,654Source | -19,067,397Source | -12,332,008Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -22,197,867Source | -15,312,654Source | -19,438,537Source | -12,332,008Source |
| Nonoperating Income (Expense)USD | -4,654,188Source | -2,638,730Source | 569,071Source | 2,708,012Source |
| Operating ExpensesUSD | 17,540,259Source | 12,377,245Source | 19,664,068Source | 15,045,139Source |
| Proceeds from Contributions from ParentUSD | 59,325Source | 440,675Source | — | — |
| Proceeds from Issuance of Common StockUSD | 3,581,500Source | 3,293,397Source | 26,864,570Source | 3,278,869Source |
income statement · annual statements
| Line item | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|
| Total RevenueUSD | 0Source | 57,321Source | 27,600Source | 5,119Source |
| Selling, General and Administrative ExpenseUSD | 4,325,645Source | 7,415,049Source | 8,365,137Source | 6,374,429Source |
| Operating Income (Loss)USD | -17,540,259Source | -12,319,924Source | -19,636,468Source | -15,040,020Source |
| Income Tax Expense (Benefit)USD | 3,420Source | 4,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -22,197,867Source | -14,962,654Source | -19,067,397Source | -12,332,008Source |
| Additional Financial Items | ||||
| Deconsolidation, Revaluation of Retained Investment, Gain (Loss), AmountUSD | -81,155Source | 911,000Source | — | — |
| Depreciation, Depletion and Amortization, NonproductionUSD | 521,860Source | — | — | — |
| Interest ExpenseUSD | 15,343Source | 3,551,482Source | 3,899,967Source | 504,858Source |
| Investment Income, InterestUSD | — | 978Source | 3,052Source | 5,466Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -22,197,867Source | -15,312,654Source | -19,438,537Source | -12,332,008Source |
| Nonoperating Income (Expense)USD | -4,654,188Source | -2,638,730Source | 569,071Source | 2,708,012Source |
| Operating ExpensesUSD | 17,540,259Source | 12,377,245Source | 19,664,068Source | 15,045,139Source |
| Other IncomeUSD | 0Source | 1,888Source | — | — |
| Research and Development ExpenseUSD | 2,788,938Source | 4,962,196Source | 11,298,931Source | 8,670,710Source |